You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 30 April 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1613095

Corrigendum: Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma

  • 1. Department of Pathology, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, China

  • 2. Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

  • 3. Department of Oncology, The Affiliated Huai’an Hospital of Xuzhou Medical University and the Second People’s Hospital of Huai’an, Huai’an, China

  • 4. Department of Thoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China

  • 5. Department of Geriatrics, The Affiliated Huai’an Hospital of Xuzhou Medical University and the Second People’s Hospital of Huai’an, Huai’an, China

Article metrics

View details

1,6k

Views

454

Downloads

In the original article, there was an error in the author list. The first author’s name was incorrectly listed as “Ding Yang” instead of the correct name “Yang Ding”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

non-small cell lung cancer, lung adenocarcinoma, single-cell RNA sequencing, prognosis signature, machine learning

Citation

Ding Y, Wang D, Yan D, Fan J, Ding Z and Xue L (2025) Corrigendum: Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma. Front. Immunol. 16:1613095. doi: 10.3389/fimmu.2025.1613095

Received

16 April 2025

Accepted

17 April 2025

Published

30 April 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Zongli Ding, ; Lei Xue,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics